Announcement
23 Oct 2026
: M42 and Inocras announce strategic collaboration to advance earlier detection of cancer recurrence in the UAE using whole genome powered MRD technology
Learn More

The Role of Artificial Intelligence in Personalized Health and Precision Care

14 May 2024
Artificial Intelligence and Technology in Healthcare
Abu Dhabi Global Healthcare Week

About the Speakers

  • Amandeep Bhangu
    Presenter & Moderator for Voice Media London
  • Ashish Koshy
    Group Chief Operating Officer M42
  • Dr. David Sinclair
    AO, PhD, Professor of Genetics for Harvard Medical School
  • James R. Mault, MD, FACS
    Founder & Chief Executive Officer, BioIntelliSense

    James Mault, MD, is the Founder and CEO of BioIntelliSense, pioneering a platform that delivers medical-grade biosensors for scalable patient monitoring and clinical intelligence.

    Watch Next